ANIK Anika Therapeutics Inc.
$20.86▼ -0.62%
Healthcare
Other
After hours
$20.86▲ +0.00%
Sep 11, 7:30 PM ET
Volume 70.3K
Avg Volume (10D) 93.0K
Key Metrics & Fundamentals
Market Cap
$279.17M
P/E Ratio
–
Div Yield
–%
52W Range
8.52 - 22.88
% vs 50 MA
10.64%
% vs 200 MA
47.20%
RSI-14
54.2
MACD Histogram
-0.2400
Beta (1Y vs SPY)
0.67
Free Cash Flow
-$2.13M
Gross Rev
$32.61M
Gross Profit
$21.24M
EBITDA
$4.46M
COGS
$11.37M
Operating Exp
$18.29M
Operating Income
$2.95M
EBIT
$2.95M
Pretax Income
$3.38M
Net Income
$3.31M
EPS (Diluted)
0.24
Price & Volume History
Loading chart…
Recent News

FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug
Zacks · Sep 9, 2026 2:05 PM

QURE Submits Application for Gene Therapy for Huntington's Disease
Zacks · Sep 3, 2026 2:30 PM

OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
Zacks · Sep 2, 2026 2:52 PM

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation
Zacks · Sep 1, 2026 4:05 PM

JAZZ Rises on Updated OS Results From Gastric Cancer Study
Zacks · Sep 1, 2026 4:02 PM

ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
Zacks · Aug 28, 2026 3:10 PM

Best Momentum Stocks to Buy for August 26th
Zacks · Aug 26, 2026 2:00 PM

Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks · Aug 24, 2026 12:55 PM

Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
Zacks · Aug 21, 2026 3:39 PM

AMLX Rises as Avexitide Nears 2026-End Filing With Phase III Study Win
Zacks · Aug 19, 2026 4:18 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ANIK's money flow as a full page
Social Sentiment
No Reddit posts found for ANIK.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.